Dr. Folker Ruchatz

Biography

Corporate Vice President Product Supply and Lifecycle Management Human Pharma Boehringer Ingelheim GmbH Dr. Ruchatz is the Vice President of Corporate Product Supply and Lifecycle Management Human Pharma at Boehringer Ingelheim GmbH. He is responsible for the product supply and the portfolio/lifecycle management of Boehringer Ingelheim’s Corporate Division Human Pharma Supply and Global Quality. Previously he was responsible for the company’s external network of suppliers and all operations for consumer health care products. Joining the company in 2013, he first served as senior vice president of the contract manufacturing business biopharmaceuticals where he led new business strategies resulting in strong and profitable growth for the division. His prior work experience was at BASF Corporation. During that time, he was vice president of global business development customer synthesis and vice president of pharma solutions and dietary supplements. Dr. Ruchatz has served as a member of DCAT’s Executive Committee since 2011. He was also a board member of the European Fine Chemical Group and Chairman of its Global Steering Committee of EXCiPACT.

Research Interest

Corporate Vice President Product Supply and Lifecycle Management Human Pharma Boehringer Ingelheim GmbH Dr. Ruchatz is the Vice President of Corporate Product Supply and Lifecycle Management Human Pharma at Boehringer Ingelheim GmbH. He is responsible for the product supply and the portfolio/lifecycle management of Boehringer Ingelheim’s Corporate Division Human Pharma Supply and Global Quality. Previously he was responsible for the company’s external network of suppliers and all operations for consumer health care products. Joining the company in 2013, he first served as senior vice president of the contract manufacturing business biopharmaceuticals where he led new business strategies resulting in strong and profitable growth for the division. His prior work experience was at BASF Corporation. During that time, he was vice president of global business development customer synthesis and vice president of pharma solutions and dietary supplements. Dr. Ruchatz has served as a member of DCAT’s Executive Committee since 2011. He was also a board member of the European Fine Chemical Group and Chairman of its Global Steering Committee of EXCiPACT.